Literature DB >> 12432573

Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells.

Eckart Schott1, Hidde L Ploegh.   

Abstract

Although the role of CD8 as a supplier of lck is unchallenged, its role in contributing to the formation of a stable complex between class I molecules and the TCR, as well as its role as an adhesion molecule, is less clear. To address the role of CD8/MHC-I interactions, we generated tetramers composed of H2-K(b) molecules with mutations in the alpha 3 domain of H2-K(b) that abolish CD8 binding. We show that the ability of tetramers to stain and activate CD8 T cells is strongly dependent on binding of CD8 to the same class I molecule engaged by the TCR. We characterize a mutation in the alpha 3 domain that results in H2-K(b) molecules capable of staining specific CD8 T cells with little ensuing activation. Although CD8 to some extent serves an adhesive function, this contribution is modest and does not substitute for lack of binding of CD8 to the class I molecule engaged by the TCR. We show that CD8 and the TCR associate in a process independent of binding of CD8 to class I. Our data support the notion that CD8 is required to form a stable complex between class I and the TCR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432573     DOI: 10.1002/1521-4141(200212)32:12<3425::AID-IMMU3425>3.0.CO;2-7

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules.

Authors:  Richard L Wong; Bai Liu; Xiaoyun Zhu; Lijing You; Lin Kong; Kai-Ping Han; Hyung-Il Lee; Pierre-Andre Chavaillaz; Moonsoo Jin; Yi Wang; Peter R Rhode; Hing C Wong
Journal:  Protein Eng Des Sel       Date:  2010-12-21       Impact factor: 1.650

Review 3.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

4.  Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction.

Authors:  Moumita Paul-Heng; Mario Leong; Eithne Cunningham; Daniel L J Bunker; Katherine Bremner; Zane Wang; Chuanmin Wang; Szun Szun Tay; Claire McGuffog; Grant J Logan; Ian E Alexander; Min Hu; Stephen I Alexander; Tim D Sparwasser; Patrick Bertolino; David G Bowen; G Alex Bishop; Alexandra Sharland
Journal:  JCI Insight       Date:  2018-08-09

5.  Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation.

Authors:  Jan Gutermuth; Kristine E Nograles; Fumi Miyagawa; Emily Nelson; Young-Hun Cho; Stephen I Katz
Journal:  J Immunol       Date:  2009-08-12       Impact factor: 5.422

6.  MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.

Authors:  Linda Wooldridge; Mathew Clement; Anna Lissina; Emily S J Edwards; Kristin Ladell; Julia Ekeruche; Rachel E Hewitt; Bruno Laugel; Emma Gostick; David K Cole; Reno Debets; Cor Berrevoets; John J Miles; Scott R Burrows; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

7.  Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.

Authors:  Linda Wooldridge; Hugo A van den Berg; Meir Glick; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Anita Milicic; Jason M Brenchley; Daniel C Douek; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

8.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

9.  Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

10.  Elimination in vivo of developing T cells by natural killer cells.

Authors:  Eckart Schott; Roberto Bonasio; Hidde L Ploegh
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.